Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 07:00 am Sale | 13G | Replimune Group Inc. REPL | Forbion Capital Fund III Cooperatief U.A. | 5,115,121 7.500% | -76,500 (-1.47%) | View |
| 2024-02-14 07:21 am Purchase | 13G | Replimune Group Inc. REPL | Forbion Capital Fund III Cooperatief U.A. | 5,191,621 8.700% | 76,500 (+1.50%) | View |
| 2024-02-14 07:21 am Sale | 13G | enGene Holdings Inc. ENGN | Forbion Capital Fund III Cooperatief U.A. | 3,369,275 14.200% | -536 (-0.02%) | View |
| 2023-11-13 4:01 pm Purchase | 13G | enGene Holdings Inc. ENGN | Forbion Capital Fund III Cooperatief U.A. | 3,369,811 14.200% | 3,369,811 (New Position) | View |
| 2021-02-16 06:36 am Unchanged | 13G | Replimune Group Inc. REPL | Forbion Capital Fund III Cooperatief U.A. | 5,115,121 11.130% | 0 (Unchanged) | View |
| 2021-02-16 06:10 am Sale | 13G | MILESTONE PHARMACEUTICALS INC MIST | Forbion Capital Fund III Cooperatief U.A. | 0 0.000% | -1,303,902 (Position Closed) | View |
| 2020-02-11 5:05 pm Purchase | 13G | Replimune Group Inc. REPL | Forbion Capital Fund III Cooperatief U.A. | 5,115,121 14.450% | 145,000 (+2.92%) | View |
| 2020-02-11 5:04 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | Forbion Capital Fund III Cooperatief U.A. | 1,303,902 5.300% | 1,303,902 (New Position) | View |